NCT06215989View on ClinicalTrials.gov

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

NARecruitingINTERVENTIONAL
Enrollment

6,574

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

June 30, 2028

Conditions
Acute Coronary SyndromeUnstable AnginaST Elevation Myocardial InfarctionNon ST Segment Elevation Myocardial InfarctionColchicine
Interventions
DRUG

Colchicine Pill

Colchicine 0.5mg once daily will be given on the basis of standard treatment of ACS recommended by guidelines

DRUG

Placebo

Placebo one tablet once daily will be given on the basis of standard treatment of ACS recommended by guidelines

Trial Locations (1)

100029

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER